Rocket Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $10,312 | $0 |
Gross Profit | -2,339 | -2,254 | 5,156 | -1,761 |
EBITDA | -71,373 | -65,120 | -57,255 | -65,429 |
EBIT | -73,712 | -67,374 | -59,621 | -67,190 |
Net Income | -69,646 | -62,054 | -59,660 | -61,899 |
Net Change In Cash | 0 | 0 | 10,312 | 0 |
Free Cash Flow | -55,782 | -58,918 | -33,986 | -61,803 |
Cash | 38,607 | 35,276 | 55,904 | 225,657 |
Basic Shares | 93,746 | 93,549 | 84,009 | 82,636 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -7,098 | -6,266 | -5,373 | -1,145 |
EBITDA | -252,561 | -213,688 | -163,180 | -131,008 |
EBIT | -259,659 | -219,954 | -168,553 | -132,153 |
Net Income | -245,595 | -219,383 | -169,585 | -146,667 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -64,629 | 111,758 | ||
Free Cash Flow | -211,388 | -186,761 | -128,878 | -103,699 |
Cash | 55,904 | 140,517 | 232,694 | 297,098 |
Basic Shares | 84,009 | 68,148 | 63,235 | 55,380 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.74 |
2024-03-31 | -$0.66 |
2023-12-31 | -$0.64 |
2023-09-30 | -$0.75 |
